Common questions about our model, how we work with companies, and what makes us different.Learn More
From Pre-IND to NDA and everything in between, RRD has a proven track record of successful client engagements.Learn More
RRD’s latest news stories, press releases, and other important announcements.Read More
The current drug development model is imperfect and inefficient. The status quo is high risk, cash intensive, and time consuming.
Over the last 20 years, for every 10 compounds put into clinical studies by pharmaceutical R&D, only 1 or 2 compounds reach the market. Companies are making costly infrastructure investments before even knowing whether a product candidate is viable.
RRD has an alternative.
We deliver strategy-driven product development support that allows companies to mitigate risk, accomplish more with fewer resources, and save precious time. Our adaptable model is based on a comprehensive, regulatory-driven approach focused on quantifying and enhancing product value, aligning with each company’s fundamental goals.
This unique philosophy is aligned with both industry needs and market conditions, enabling our clients to optimize the value of their viable assets through three key principles: tactical development, value creation, and bottom line impact and, conversely, reducing the cost and time expended on ultimately non-viable product candidates.
The RRD development model is primarily focused on two distinct engagements: